Abstract
Background:
Few studies have examined the effects of nondaily smoking or low-intensity daily smoking and infant outcomes. We examined the associations between preterm delivery and small for gestational age (SGA) infants in relation to both nondaily and daily smoking.
Methods:
We used population-based data on women who delivered live singleton infants using the 2009–11 Pregnancy Risk Assessment Monitoring System. Women’s smoking status in the last 3 months of pregnancy was categorised as nonsmokers, quitters, nondaily smokers (<1 cigarette/day), and daily smokers. Controlling for maternal age, maternal race/ethnicity, education, marital status, prepregnancy body mass index (BMI), trimester of prenatal care entry, parity, and alcohol use, we estimated adjusted prevalence ratios (PR) for the outcomes of preterm delivery (<37 weeks’ gestation) and SGA.
Results:
Of the 88 933 women, 13.1%, 1.7%, and 9.6% of the sample were quitters, nondaily smokers, and daily smokers, respectively, in the last 3 months of pregnancy. While nondaily smoking was not associated with preterm delivery, daily smoking was. However, we found no dose–response relationship with the number of cigarettes smoked per day. Risk of delivering a SGA infant was increased for both nondaily and daily smokers (PR 1.4, 95% CI 1.1, 1.8 and PR 2.0, 95% CI 1.9, 2.2 respectively).
Conclusions:
Nondaily smoking in the last 3 months of pregnancy was associated with an increased risk of delivering a SGA infant. Pregnant women should be counselled that smoking, including nondaily and daily smoking, can adversely affect birth outcomes.
Keywords: Smoking, nondaily smoking, dose–response, pregnancy, infant outcomes, preterm delivery, small for gestational age
In 2014, an estimated 8% of women smoked in the last 3 months of pregnancy in the United States.1 Approximately half of women who smoke prior to pregnancy quit during pregnancy, and a substantial percentage reduce or ‘cut down’ the number of cigarettes smoked.2 Women who reduce smoking without quitting may do so to minimise harm to the fetus.3 Furthermore, nondaily smokers are becoming an increasingly larger fraction of the smoking population, which may result in more nondaily smokers in pregnancy.4
Maternal smoking is causally associated with adverse pregnancy outcomes, including foetal growth restriction, placenta abruption, and preterm delivery.5 The epidemiologic literature on the effects of maternal smoking and infant outcomes has included mostly studies of daily smokers. A meta-analysis of 20 prospective studies reported a modest 27% increase in risk of preterm delivery among daily smokers.6 None of these studies examined the association between nondaily smoking and preterm delivery. Relative risk estimates for small for gestational age (SGA) have ranged from 1.5 to 2.5 in daily smokers.5 A dose–response relationship between the number of cigarettes smoked per day and reductions in birthweight have been shown; however, few studies have examined the effects of low-intensity daily smoking on fetal growth.7,8 We examined the associations between preterm delivery and SGA infants in relation to both nondaily and daily smoking.
Methods
We used population-based surveillance data from women delivering singleton livebirths using the 2009–11 Pregnancy Risk Assessment Monitoring System (PRAMS). The methodology has been described elsewhere.9 Briefly, at each site a monthly stratified sample of 100–300 new mothers is selected systematically from birth certificate records. We included New York City and 31 states that achieved an overall weighted response rate of ≥65% for a given site and year in the study period. The PRAMS protocol was approved by institutional review boards at the Centers for Disease Control and Prevention and participating states.
Women who reported smoking in the past 2 years were asked in the PRAMS survey how many cigarettes they smoked per day on average during the 3 months before pregnancy and in the last 3 months of pregnancy. Categorical responses were none (0 cigarettes), <1, 1–5, 6–10, 11–20, 21–40, or ≥41 cigarettes smoked per day. Nonsmokers were women who reported no smoking before or during pregnancy. Quitters were women who reported any smoking before pregnancy and ‘none’ during pregnancy. Nondaily smokers were women who reported any smoking before pregnancy and <1 cigarette smoked per day during pregnancy. Daily smokers were women who reported any smoking before pregnancy and ≥1 cigarettes smoked per day during pregnancy.
Preterm delivery was defined as <37 completed weeks of gestation based on the clinical estimate of gestation from the birth certificate. SGA was defined as the lowest 10th percentile of birthweight (also obtained from the birth certificate) for gestational age by infant sex and race.10 Covariates were selected based on established associations with smoking and birth outcomes:11 maternal age, parity, race/ethnicity, education, marital status, prepregnancy body mass index (BMI), trimester of prenatal care entry, and alcohol use during pregnancy.
The analysis was restricted to women delivering singleton livebirths and whose smoking status, gestational age and birthweight were not missing. Demographic characteristics were compared by smoking status (nonsmokers, quitters, nondaily smokers, and daily smokers). Prevalence and adjusted PR for preterm delivery and SGA by smoking status were estimated, controlling for maternal age, parity, race/ethnicity (excluded from the SGA model), education, marital status, prepregnancy BMI, trimester of prenatal care entry, and alcohol use. Because chronic and gestational hypertension are associated with smoking and poor pregnancy outcomes, we repeated the analyses of preterm delivery and of SGA after excluding women with hypertension complications. Analyses were conducted using SAS version 9.3 (SAS Institute, Inc., Cary, NC, USA) and SUDAAN version 11 (RTI International, Raleigh, NC, US) to account for the complex survey design of PRAMS.
Results
Of the 105 778 women, 88 933 (84%) had non-missing smoking status, infant outcomes, and covariates. Overall, 13.1%, 1.7%, and 9.6% of the sample were quitters, nondaily smokers, and daily smokers during pregnancy respectively (Table 1).
Table 1.
Non-smokers (n = 64 860) % (95% CI) | Quitters (n = 11 696) % (95% CI) | Nondaily smokers (n = 1694) % (95% CI) | Daily smokers (n = 10 683) % (95% CI) | |
---|---|---|---|---|
Total | 75.6 (75.1, 76.1) | 13.1 (12.7,13.5) | 1.7 (1.6,1.9) | 9.6 (9.3, 9.9) |
Maternal age (years) | ||||
<20 | 7.9 (7.5, 8.3) | 12.9 (11.8,14.0) | 12.9 (10.1,16.3) | 11.8 (10.7,13.0) |
20–24 | 19.1 (18.5,19.6) | 31.5 (30.1,33.0) | 34.9 (30.9, 39.1) | 35.3 (33.6, 36.9) |
25–34 | 57.0 (56.3, 57.6) | 47.6 (46.0, 49.1) | 46.1 (41.9,50.3) | 45.6 (43.9, 47.4) |
≥35 | 16.1 (15.6,16.5) | 8.1 (7.3, 8.9) | 6.2 (4.4, 8.6) | 7.3 (6.6, 8.2) |
Maternal race/ethnicity | ||||
White, non-Hispanic | 57.5 (56.9,58.0) | 69.9 (68.5,71.3) | 62.4 (58.1,66.6) | 80.1 (78.8,81.4) |
Black, non-Hispanic | 13.4 (13.1,13.8) | 10.7 (9.8,11.5) | 14.8 (12.4,17.7) | 9.8 (8.9, 10.7) |
Hispanic | 20.4 (20.0, 20.9) | 13.1 (11.9,14.4) | 15.1 (11.6,19.3) | 4.9 (4.1, 5.8) |
American Indian/Alaska Native | 0.5 (0.5, 0.6) | 1.7 (1.5, 2.0) | 2.6 (1.8, 3.7) | 1.6 (1.4,1.9) |
Asian/Pacific Islander | 6.0 (5.8, 6.2) | 2.1 (1.8, 2.5) | 2.0 (1.3, 3.1) | 0.9 (0.8,1.2) |
Other | 2.1 (1.9, 2.3) | 2.4 (2.0, 2.9) | 3.1 (1.8, 5.3) | 2.7 (2.2, 3.2) |
Maternal education (years) | ||||
<12 | 13.7 (13.2,14.2) | 14.6 (13.5,15.7) | 20.7 (17.5, 24.5) | 27.2 (25.6, 28.8) |
12 | 22.1 (21.5, 22.7) | 33.4(31.9,34.9) | 38.8 (34.6, 43.2) | 42.6 (40.9, 44.4) |
≥13 | 64.2 (63.6, 64.8) | 52.1 (50.5,53.6) | 40.4 (36.4, 44.5) | 30.2 (28.6,31.8) |
Marital status | ||||
Unmarried | 30.8 (30.2,31.5) | 53.6(52.1,55.1) | 63.5 (59.3,67.5) | 67.9 (66.2, 69.4) |
Married | 69.2 (68.5, 69.8) | 46.4 (44.9, 47.9) | 36.5 (32.5,40.7) | 32.1 (30.6, 33.8) |
Prepregnancy body mass index (kg/m2) | ||||
Underweight (<18.5) | 4.0 (3.8, 4.2) | 4.5 (3.9,5.2) | 4.9 (3.4, 7.0) | 6.7 (5.9, 7.6) |
Normal weight (18.5–24.9) | 51.7 (51.0,52.3) | 46.3 (44.8, 47.9) | 46.9(42.6,51.2) | 45.5 (43.8, 47.2) |
Overweight (25.0–29.9) | 24.1 (23.5, 24.7) | 24.6 (23.3, 26.0) | 25.4 (22.0, 29.2) | 23.1 (21.7,24.6) |
Obese (≥30) | 20.2 (19.7, 20.8) | 24.6 (23.2, 26.0) | 22.8 (19.4, 26.7) | 24.7 (23.3, 26.2) |
Parity | ||||
First birth | 41.7 (41.1, 42.4) | 53.2(51.7,54.8) | 47.3 (43.0,51.6) | 36.8 (35.1,38.4) |
Second or later birth | 58.3 (57.6,58.9) | 46.8 (45.2, 48.3) | 52.7 (48.4, 57.0) | 63.2 (61.6,64.9) |
Entry into prenatal care | ||||
First trimester | 83.1 (82.6, 83.6) | 80.2 (78.9,81.5) | 78.5 (74.5,82.1) | 73.7 (72.1, 75.2) |
Second trimester | 12.9 (12.5, 13.4) | 16.0 (14.8,17.2) | 15.7 (12.7,19.3) | 20.2 (18.8, 21.6) |
Third trimester or none | 4.0 (3.7, 4.3) | 3.8 (3.2, 4.5) | 5.7 (3.8, 8.6) | 6.1 (5.3, 7.1) |
Alcohol use during pregnancy | ||||
Yes | 7.4 (7.1, 7.7) | 6.7 (5.9, 7.5) | 8.6 (6.8,10.8) | 6.9 (6.1, 7.8) |
No | 92.6 (92.3, 92.9) | 93.3 (92.5, 94.1) | 91.4 (89.2,93.2) | 93.1 (92.2, 93.9) |
CI, confidence interval.
The prevalence of preterm delivery was not different between quitters or nondaily smokers compared with nonsmokers (Table 2). Preterm delivery prevalence was higher in daily smokers compared with nonsmokers overall, in low-intensity daily smokers (1–5 cigarettes/day) and 6–10 cigarettes/day daily smokers. The point estimates for preterm delivery prevalence were higher for higher intensity (11–20 and ≥21 cigarettes/day) daily smokers compared with nonsmokers (Table 2), but there was no evidence of a dose–response relationship between cigarettes smoked per day and risk of preterm delivery. When we excluded women with hypertension, preterm delivery was associated with daily smoking (PR 1.3, 95% CI 1.2, 1.5), but not with nondaily smoking (PR 1.0, 95% CI 0.8, 1.3).
Table 2.
Prevalence ratio (95% CI) | |||
---|---|---|---|
Smoking status | Prevalence % (95% CI) | Unadjusted | Adjusted |
Nonsmokers (n = 64 860) | 7.4 (7.1, 7.7) | 1.0 (Reference) | 1.0 (Reference) |
Quitters (n = 11 696) | 7.6 (6.9, 8.4) | 1.0 (0.9,1.1) | 1.0 (0.9,1.2) |
Nondaily smokers (n = 1694) | 7.5 (6.1, 9.2) | 1.0 (0.8,1.3) | 1.0 (0.8,1.2) |
Daily smokers (n = 10 683) | 9.5 (8.8,10.3) | 1.3 (1.2,1.4) | 1.3 (1.2,1.4) |
1–5 cigs/day (n = 5432) | 9.9(8.8,11.0) | 1.3 (1.2,1.5) | 1.3 (1.2,1.5) |
6–10 cigs/day (n = 3239) | 9.3 (8.0,11.0) | 1.3 (1.1,1.5) | 1.3 (1.1,1.5) |
11–20 cigs/day (n = 1656) | 8.6 (6.9,10.6) | 1.2 (0.9,1.4) | 1.2 (1.0,1.5) |
≥21 cigs/day (n = 356) | 10.6 (6.8,16.0) | 1.4 (0.9, 2.2) | 1.4 (0.9, 2.2) |
CI, confidence interval.
Prevalence ratios are adjusted for maternal age, race/ethnicity, education, marital status, parity, prepregnancy body mass index, trimester of entry into prenatal care, and alcohol use during pregnancy.
Daily smokers include all women who smoked ≥1 cigarettes smoked per day.
The prevalence of SGA was not different for quitters compared with nonsmokers; however, the prevalence of SGA was higher for nondaily and daily smokers compared with nonsmokers (Table 3). A dose–response relationship was observed between SGA and smoking intensity among daily smokers.
Table 3.
Prevalence ratio (95% CI) | |||
---|---|---|---|
Smoking status | Prevalence % (95% CI) | Unadjusted | Adjusted |
Nonsmokers (n = 64 860) | 8.6 (8.3, 9.0) | 1.0 (Reference) | 1.0 (Reference) |
Quitters (n = 11 696) | 8.9 (8.1,9.7) | 1.0 (0.9,1.1) | 0.9 (0.9,1.0) |
Nondaily smokers (n = 1694) | 13.4 (10.8,16.4) | 1.6 (1.3,1.9) | 1.4 (1.1, 1.8) |
Daily smokers (n = 10 683) | 18.9 (17.6, 20.2) | 2.2 (2.0, 2.4) | 2.0 (1.9,2.2) |
1–5 cigs/day (n = 5432) | 17.6 (16.0,19.3) | 2.1 (1.9, 2.3) | 1.9 (1.7,2.1) |
6–10 cigs/day (n = 3239) | 18.7 (16.5, 21.1) | 2.2 (1.9, 2.5) | 2.0 (1.8, 2.3) |
11–20 cigs/day (n = 1656) | 21.5 (18.1, 25.3) | 2.5 (2.1, 3.0) | 2.4 (2.0, 2.9) |
≥21 cigs/day (n = 356) | 25.8 (19.0,34.0) | 3.0 (2.3, 4.0) | 2.9 (2.1,4.0) |
CI, confidence interval.
Prevalence ratios are adjusted for maternal age, education, marital status, parity, prepregnancy body mass index, trimester entry into prenatal care, and alcohol use during pregnancy.
Daily smokers include all women who smoked ≥1 cigarettes smoked per day.
Comment
We found that nondaily smoking in the last 3 months of pregnancy was associated with a 1.4-fold increased risk of delivering an SGA infant compared with nonsmokers. As expected, we found modest associations between daily smoking and both SGA and preterm delivery. The prevalence of SGA increased in a dose–response fashion from nondaily to daily smoking as the number of cigarettes smoked per day increased. This finding is also consistent with previous studies in which low levels of tobacco smoking had significant effects on fetal growth.5 England and colleagues8 found infant birthweight declined sharply at low levels of tobacco exposure.
We did not find an association between preterm delivery and nondaily smoking, nor did we find a dose–response relationship between preterm delivery and cigarettes smoked per day in daily smokers. A meta-analysis6 reported a dose–response relationship between preterm delivery and the number of cigarettes smoked per day at low- to moderate-intensity smoking, but was not further increased at 20 cigarettes or more smoked per day. Despite the lack of dose–response relationship, evidence from animal models suggests that even low levels of smoking could have important effects on offspring neurological development.12
The findings in this study have implications for clinical care. First, pregnant women should be screened for all tobacco use, including nondaily smoking.13 Second, the findings are consistent with other studies that have shown that low levels of daily smoking (e.g. 1–5 cigarettes/day) had adverse effects on preterm birth and fetal growth. Although some have advocated reducing the number of cigarettes smoked for pregnant women who do not quit smoking based on improvements in birthweights compared with other smokers,3,14 there is limited evidence that reduction alone has other substantial health benefits. Quitting smoking completely is the most beneficial for a pregnant woman, her fetus, and her baby.13 Therefore, pregnant women should be advised that smoking low levels of smoking, both nondaily and daily smoking, confers adverse effects on the fetus.
This study has several limitations. Smoking status was self-reported and not biochemically verified. PRAMS is a confidential survey, and may identify more smokers than other data sources based on self-report, such as the birth certificate.15 Nevertheless, misclassification of smokers as nonsmokers and potential recall bias, as the PRAMS survey is answered about 4 months postpartum, could bias our results towards the null. Second, nondaily smoking was defined using the response <1 cigarette smoked/day; some daily smokers who smoked part of a cigarette could have selected this option, or daily smokers could have misreported their use as nondaily smoking. These types of misclassification could have resulted in an overestimation of the association between nondaily smoking and adverse outcomes. However, we did not see an increased risk of preterm delivery in nondaily smokers which supports that there was not extensive misclassification in this direction. Third, we were unable to account for second hand smoke exposure or illicit substance use, which may have confounded our results. Finally, our findings may not be generalisable to women whose pregnancies did not result in livebirths.
In conclusion, we found evidence that nondaily smoking during the last 3 months of pregnancy is associated with fetal growth restriction. The findings provide further evidence that even low level levels of smoking can put a pregnancy at risk for adverse birth outcomes.
Acknowledgements
The authors acknowledge the Pregnancy Risk Assessment Monitoring System Working Group. A List of members is available at: http://www.cdc.gov/prams/pdf/researchers/prams-working-group_508tagged.pdf
Footnotes
Disclosure
The authors report no conflict of interest. No funding was involved in the conduct of this study. This research was supported in part by an appointment to the Research Participation Program at the Centers for Disease Control and Prevention administered by the Oak Ridge Institute for Science and Education through an interagency agreement between the US Department of Energy and CDC. The findings and conclusions in this article are those of the authors and do not necessarily represent the official position of the Centers for Disease Control and Prevention.
References
- 1.Curtin SM, Mathews TJ. Smoking prevalence and cessation before and during pregnancy: Data from the birth certificate National Vital Statistics Reports 2016; vol 65 Hyattsville, MD: National Center for Health Statistics, 2014. [PubMed] [Google Scholar]
- 2.Tong VT, Dietz PM, Morrow B, D’Angelo DV, Farr SL, Rockhill KM, et al. Trends in smoking before, during, and after pregnancy–Pregnancy Risk Assessment Monitoring System, United States, 40 sites, 2000–2010. Morbidity and Mortality Weekly ReportSurveillance Summaries 2013; 62:1–19. [PubMed] [Google Scholar]
- 3.Li CQ, Windsor RA, Perkins L, Goldenberg RL, Lowe JB. The impact on infant birth weight and gestational age of cotinine-validated smoking reduction during pregnancy. JAMA 1993; 269:1519–1524. [PubMed] [Google Scholar]
- 4.Jamal A, Agaku IT, O’Connor E, King BA, Kenemer JB, Neff L. Current cigarette smoking among adults–United States, 2005–2013. Morbidity and Mortality Weekly Report 2014; 63:1108–1112. [PMC free article] [PubMed] [Google Scholar]
- 5.CDC. The Health Consequences of Smoking: 50 Years of Progress: A Report of the Surgeon General. Atlanta, GA: US Department of Health and Human Services, CDC, National Center for Chronic Disease Prevention and Health Promotion, Office on Smoking and Health, 2014. [Google Scholar]
- 6.Shah NR, Bracken MB. A systematic review and meta-analysis of prospective studies on the association between maternal cigarette smoking and preterm delivery. American Journal of Obstetrics and Gynecology 2000; 182:465–472. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7.Blatt K, Moore E, Chen A, Van Hook J, DeFranco EA. Association of reported trimester-specific smoking cessation with fetal growth restriction. Obstetrics & Gynecology 2015; 125:1452–1459. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 8.England LJ, Kendrick JS, Gargiullo PM, Zahniser SC, Hannon WH. Measures of maternal tobacco exposure and infant birth weight at term. American Journal of Epidemiology. 2001; 153(10):954–960. [DOI] [PubMed] [Google Scholar]
- 9.Shulman HB, Gilbert BC, Gilbert BC, Lansky A. The Pregnancy Risk Assessment Monitoring System (PRAMS): current methods and evaluation of 2001 response rates. Public Health Reports 2006; 121:74–83. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 10.Alexander GR, Tompkins ME, Allen MC, Hulsey TC. Trends and racial differences in birth weight and related survival. Maternal and Child Health Journal 1999; 3:71–79. [DOI] [PubMed] [Google Scholar]
- 11.Chamberlain C, O’Mara-Eves A, Oliver S, Caird JR, Perlen SM, Eades SJ, et al. Cochrane Database of Systematic Reviews 2013; 10:CD001055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 12.England LJ, Aagaard K, Bloch M, Conway K, Cosgrove K, Grana R, et al. Developmental toxicity of nicotine: A transdisciplinary synthesis and implications for emerging tobacco products. Neuroscience & Biobehavioral Reviews 2017; 72: 176–189. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 13.Committee opinion no. 471: Smoking cessation during pregnancy. Obstetrics & Gynecology 2010; 116:1241–1244. [DOI] [PubMed] [Google Scholar]
- 14.Yan J, Groothuis PA. Timing of prenatal smoking cessation or reduction and infant birth weight: evidence from the United Kingdom Millennium Cohort Study. Maternal and Child Health Journal 2015; 19:447–458. [DOI] [PubMed] [Google Scholar]
- 15.Tong VT, Dietz PM, Farr SL, D’Angelo DV, England LJ. Estimates of smoking before and during pregnancy, and smoking cessation during pregnancy: comparing two population-based data sources. Public Health Reports 2013; 128:179–188. [DOI] [PMC free article] [PubMed] [Google Scholar]